We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Improved Survival Rates Following Aortic Dissection

By HospiMedica International staff writers
Posted on 03 Nov 2014
A new study reveals that although hospitalization rates for aortic dissection (AD) have remained stable, mortality survival rates have improved, particularly in patients undergoing surgical repair.

Researchers at the University of Texas Southwestern Medical Center (Dallas, TX, USA), Yale-New Haven Hospital (YNHH; New Haven, CT, USA), and other institutions reviewed US inpatient Medicare data from 2000 to 2011 to determine trends in hospitalization rates for AD; mortality rates were ascertained through corresponding vital status files. More...
In all, 32,057 initial AD hospitalizations were identified. The overall hospitalization rate for AD remained unchanged, at 10 per 100,000 person-years.

The results showed that for 30-day and one-year mortality associated with AD, the observed rate decreased from 31.8% to 25.4% and from 42.6% to 37.4%, respectively. For patients undergoing surgical repair for type A dissections, the observed 30-day mortality decreased from 30.7% to 21.4%, and the observed one-year mortality decreased from 39.9% to 31.6%. For surgical repair of type B dissections, the 30-day mortality decreased from 24.9% to 21%, and the one-year rate decreased from 36.4% to 32.5%. The study was published in the November 2014 issue of Circulation: Cardiovascular Quality and Outcomes.

“The reason for the improvement in mortality in operative patients might have been subtle improvements on various fronts, such as neuroprotection, improved intraoperative and postoperative pharmacological therapy, operative algorithm and standardized cannulation techniques, and development of care teams,” concluded senior author Harlan Krumholz, MD, of YNNH, and colleagues. “Additionally, part of the improvement in mortality seen with type B dissection could be possible because of the increasing use of the endovascular approach in the treatment of surgically high-risk patients.”

AD occurs when a tear in the inner wall of the aorta causes blood to flow between the layers of the wall of the aorta, forcing them apart. In most cases this is associated with severe characteristic chest or abdominal pain, often with other symptoms that result from decreased blood supply to other organs. The Stanford classification divides AD into two groups; in type A, the ascending aorta and/or aortic arch, and possibly the descending aorta are involved. In type B, the descending aorta or the arch (distal to the left subclavian artery) is dissected, without involvement of the ascending aorta.

Related Links:

University of Texas Southwestern Medical Center
Yale-New Haven Hospital



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammography System (Analog)
MAM VENUS
MRI System
nanoScan MRI 3T/7T
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.